See All Slides - tctmd.com

Slides

Presentation TCT 2014

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Presenter: Dietmar Trenk

September 16, 2014

Presentation TCT 2014

Treatment of Rabbit Aneurysms with the Intracranial Multilayer Flow Modulator

Presenter: Edel Kavanagh

September 16, 2014

Presentation TCT 2014

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Presenter: Krishnankutty Sudhir

September 16, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Arif Al Nooryani

September 15, 2014

Presentation TCT 2014

Novel Sheath Technology for TAVR

Presenter: Hemal Gada

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Yoshinobu Onuma

September 15, 2014

Presentation TCT 2014

New Dedicated Guidewires for TAVR

Presenter: Wesley R. Pedersen

September 15, 2014

Presentation TCT 2014

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran

September 15, 2014

Presentation TCT 2014

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Ning Guo

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Jens Flensted Lassen

September 15, 2014

Advertisement

Slides

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Treatment of Rabbit Aneurysms with the Intracranial Multilayer Flow Modulator

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Novel Sheath Technology for TAVR

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

New Dedicated Guidewires for TAVR

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content